Cargando…

Diffusion-weighted MRI distinguishes Parkinson disease from the parkinsonian variant of multiple system atrophy: A systematic review and meta-analysis

BACKGROUND: Putaminal diffusivity in brain magnetic resonance diffusion-weighted imaging (DWI) is increased in patients with the parkinsonian variant of multiple system atrophy (MSA-P) compared to Parkinson disease (PD) patients. PURPOSE: We performed a systematic review and meta-analysis to evaluat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bajaj, Sweta, Krismer, Florian, Palma, Jose-Alberto, Wenning, Gregor K., Kaufmann, Horacio, Poewe, Werner, Seppi, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5747439/ https://www.ncbi.nlm.nih.gov/pubmed/29287113 http://dx.doi.org/10.1371/journal.pone.0189897

Ejemplares similares

Automated Analysis of Diffusion‐Weighted Magnetic Resonance Imaging for the Differential Diagnosis of Multiple System Atrophy from Parkinson's Disease
por: Krismer, Florian, et al.
Publicado: (2020)

Sensor‐based gait analysis in atypical parkinsonian disorders
por: Raccagni, Cecilia, et al.
Publicado: (2018)

Morphometric MRI profiles of multiple system atrophy variants and implications for differential diagnosis
por: Krismer, Florian, et al.
Publicado: (2019)

Disease-Modifying Therapies for Multiple System Atrophy: Where Are We in 2022?
por: Sidoroff, Victoria, et al.
Publicado: (2022)

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies
por: Krismer, Florian, et al.
Publicado: (2014)

Intact Olfaction in a Mouse Model of Multiple System Atrophy
por: Krismer, Florian, et al.
Publicado: (2013)

Cardiac sympathetic innervation in Parkinson’s disease versus multiple system atrophy
por: Eckhardt, Christine, et al.
Publicado: (2022)

Sensitivity to Change and Patient‐Centricity of the Unified Multiple System Atrophy Rating Scale Items: A Data‐Driven Analysis
por: Krismer, Florian, et al.
Publicado: (2022)

Neuroprotection by Epigenetic Modulation in a Transgenic Model of Multiple System Atrophy
por: Sturm, Edith, et al.
Publicado: (2016)

Disease Progression in Multiple System Atrophy—Novel Modeling Framework and Predictive Factors
por: Kühnel, Line, et al.
Publicado: (2022)

Limitations of the Unified Multiple System Atrophy Rating Scale as outcome measure for clinical trials and a roadmap for improvement
por: Palma, Jose-Alberto, et al.
Publicado: (2021)

An antibody microarray analysis of serum cytokines in neurodegenerative Parkinsonian syndromes
por: Mahlknecht, Philipp, et al.
Publicado: (2012)

Towards translational therapies for multiple system atrophy
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2014)

Dorsolateral Nigral Hyperintensity on 1.5 T Versus 3 T Susceptibility‐Weighted Magnetic Resonance Imaging in Neurodegenerative Parkinsonism
por: Grossauer, Anna, et al.
Publicado: (2023)

Cognition in multiple system atrophy: a single‐center cohort study
por: Eschlböck, Sabine, et al.
Publicado: (2020)

Different assessment tools to detect sarcopenia in patients with Parkinson's disease
por: Valent, Dora, et al.
Publicado: (2022)

Nomogram to Predict the Probability of Functional Dependence in Early Parkinson’s Disease
por: Valent, Dora, et al.
Publicado: (2023)

Characterization of gait variability in multiple system atrophy and Parkinson’s disease
por: Sidoroff, Victoria, et al.
Publicado: (2020)

Urodynamic Evaluation in Multiple System Atrophy: A Retrospective Cohort Study
por: Eschlböck, Sabine, et al.
Publicado: (2021)

The Concept of Prodromal Parkinson’s Disease
por: Mahlknecht, Philipp, et al.
Publicado: (2015)

Has Deep Brain Stimulation Changed the Very Long‐Term Outcome of Parkinson's Disease? A Controlled Longitudinal Study
por: Mahlknecht, Philipp, et al.
Publicado: (2020)

The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
por: Wenning, Gregor K., et al.
Publicado: (2022)

An update on the cerebellar subtype of multiple system atrophy
por: Ciolli, Ludovico, et al.
Publicado: (2014)

Multimodal striatal neuromarkers in distinguishing parkinsonian variant of multiple system atrophy from idiopathic Parkinson's disease
por: Pang, Huize, et al.
Publicado: (2022)

Non‐Motor Symptoms in Parkinson's Disease are Reduced by Nabilone
por: Peball, Marina, et al.
Publicado: (2020)

Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy
por: Stefanova, Nadia, et al.
Publicado: (2012)

Effects of Nabilone on Sleep Outcomes in Patients with Parkinson's Disease: A Post‐hoc Analysis of NMS‐Nab Study
por: Peball, Marina, et al.
Publicado: (2022)

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson’s disease
por: Hametner, Eva-Maria, et al.
Publicado: (2012)

Apomorphine for Parkinson’s Disease: Efficacy and Safety of Current and New Formulations
por: Carbone, Federico, et al.
Publicado: (2019)

Magnetic resonance imaging for the diagnosis of Parkinson’s disease
por: Heim, Beatrice, et al.
Publicado: (2017)

Eye Tracking in Patients with Parkinson’s Disease Treated with Nabilone–Results of a Phase II, Placebo-Controlled, Double-Blind, Parallel-Group Pilot Study
por: Ellmerer, Philipp, et al.
Publicado: (2022)

α‐Synuclein Seed Amplification Assays in the Diagnosis of Synucleinopathies Using Cerebrospinal Fluid—A Systematic Review and Meta‐Analysis
por: Grossauer, Anna, et al.
Publicado: (2023)

Family History for Neurodegeneration in Multiple System Atrophy: Does it Indicate Susceptibility?
por: Leys, Fabian, et al.
Publicado: (2022)

Prodromal Parkinson's disease: hype or hope for disease-modification trials?
por: Mahlknecht, Philipp, et al.
Publicado: (2022)

Is Transcranial Sonography Useful to Distinguish Scans Without Evidence of Dopaminergic Deficit Patients From Parkinson's Disease?
por: Stockner, Heike, et al.
Publicado: (2012)

Pimavanserin: A Truly Effective Treatment for Parkinson’s Disease Psychosis? A Review of Interventions
por: Heim, Beatrice, et al.
Publicado: (2023)

Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD)
por: Esterhammer, Regina, et al.
Publicado: (2015)

Orthostatic Hypotension in Parkinson's Disease: Do Height and Weight Matter?
por: Campese, Nicole, et al.
Publicado: (2021)

A multiplex pedigree with pathologically confirmed multiple system atrophy and Parkinson’s disease with dementia
por: Fanciulli, Alessandra, et al.
Publicado: (2022)

The Unified Multiple System Atrophy Rating Scale: Status, Critique, and Recommendations
por: Krismer, Florian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gk1u1rp1e4qj5244dq0bevslss